NCT06329323View on ClinicalTrials.gov

SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours

Not yet recruitingOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

April 14, 2024

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2028

Conditions
Germ Cell Ovarian CancerGerm Cell TumorGerm Cell CancerGerm Cell NeoplasiaOvary CancerOvary NeoplasmOvarian CancerOvarian Neoplasms
Interventions
DIAGNOSTIC_TEST

Blood test

Serum and plasma microRNA quantification

DIAGNOSTIC_TEST

Pathology specimen miRNA expression

Pathology specimen mirNA expression - ALL MOGCT; OPTIONAL for BOGCT

All Listed Sponsors
lead

Imperial College London

OTHER

NCT06329323 - SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours | Biotech Hunter | Biotech Hunter